254 related articles for article (PubMed ID: 21474720)
1. Infectious diseases. First specific drugs raise hopes for hepatitis C.
Enserink M
Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
[No Abstract] [Full Text] [Related]
2. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
Lange CM; Sarrazin C; Zeuzem S
Pharm Unserer Zeit; 2011 Jan; 40(1):60-7. PubMed ID: 21194084
[No Abstract] [Full Text] [Related]
3. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
Manns M
MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729
[No Abstract] [Full Text] [Related]
4. [Therapy of hepatitis C: new inhibitors as hammers against HCV].
Bublak R
MMW Fortschr Med; 2013 Jun; 155 Suppl 1():10-1. PubMed ID: 23961643
[No Abstract] [Full Text] [Related]
5. The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir.
Marks KM; Jacobson IM
Antivir Ther; 2012; 17(6 Pt B):1119-31. PubMed ID: 23188750
[TBL] [Abstract][Full Text] [Related]
6. [New times for the treatment of chronic hepatitis C].
Gerstoft J; Fomsgaard A
Ugeskr Laeger; 2012 Mar; 174(12):795. PubMed ID: 22433552
[No Abstract] [Full Text] [Related]
7. [Studies with boceprevir].
MMW Fortschr Med; 2011 Jul; 153(29-31):16. PubMed ID: 21830728
[No Abstract] [Full Text] [Related]
8. Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.
Gellad ZF; Reed SD; Muir AJ
Antivir Ther; 2012; 17(6 Pt B):1189-99. PubMed ID: 23186646
[TBL] [Abstract][Full Text] [Related]
9. New hepatitis C regimen stimulates changes in therapy management.
Reinke T
Manag Care; 2011 Dec; 20(12):41-2. PubMed ID: 22259876
[No Abstract] [Full Text] [Related]
10. New developments in HCV therapy.
Kronenberger B; Zeuzem S
J Viral Hepat; 2012 Jan; 19 Suppl 1():48-51. PubMed ID: 22233414
[TBL] [Abstract][Full Text] [Related]
11. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.
Seden K; Back D
Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895
[TBL] [Abstract][Full Text] [Related]
12. [New triple therapy in chronic hepatitis C. Increased patient chances].
Stiefelhagen P
MMW Fortschr Med; 2011 Sep; 153(39):20. PubMed ID: 21991830
[No Abstract] [Full Text] [Related]
13. [Treatment of hepatitis C infection. A revolution should not hide another].
Sogni P
Presse Med; 2014 Apr; 43(4 Pt 1):339-40. PubMed ID: 24661837
[No Abstract] [Full Text] [Related]
14. Viral hepatitis C in 2014--the beginning of the end?
Prelipcean CC; Gogălniceanu P; Mihai C
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):272-8. PubMed ID: 25076687
[No Abstract] [Full Text] [Related]
15. Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection.
Fernández-Yunquera A; Rincón D; Salcedo M; Bañares R
Rev Esp Quimioter; 2013 Sep; 26(3):189-92. PubMed ID: 24080883
[No Abstract] [Full Text] [Related]
16. [Hepatitis C update: what has changed? What can we expect in the near future?].
Geier A
MMW Fortschr Med; 2013 Nov; 155(19):59-62. PubMed ID: 24475674
[No Abstract] [Full Text] [Related]
17. Prompt arrival of antivirals against hepatitis C for HIV patients.
Barreiro P; Vispo E
AIDS Rev; 2010; 12(4):242-3. PubMed ID: 21344779
[No Abstract] [Full Text] [Related]
18. [New antiviral agents against hepatitis C in clinical trials. Hope for a cure--but resistance problems must be overcomed].
Lennerstrand J; Bondeson K; Bergqvist A; Blomberg J; Oberg B
Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3254-6, 3258, 3260. PubMed ID: 20101837
[No Abstract] [Full Text] [Related]
19. Future of hepatitis C therapy: development of direct-acting antivirals.
Dore GJ; Matthews GV; Rockstroh J
Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
[TBL] [Abstract][Full Text] [Related]
20. Telaprevir: hope on the horizon, getting closer.
Weisberg IS; Jacobson IM
Clin Liver Dis; 2009 Aug; 13(3):441-52. PubMed ID: 19628160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
